Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke | MicrobiomeTrials← Back to trialsNCT07609654
Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-10-26Est. Completion: 2031-11-01
Enrollment target: 852 participants Locations- Department of Neurology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhengjiang, China
Other microbiome trials you might be interested in
Moyamoya DiseaseMoyamoya Syndrome
This multicenter prospective observational cohort study aims to develop and validate individualized risk prediction mode…
Beijing, ChinaEst. completion Feb 28, 2030
Moyamoya Disease
Moyamoya disease is a relatively rare chronic cerebrovascular disease, and its exact cause is currently unknown. This di…
Nanjing, ChinaCompleted Jan 31, 2027
Phase 3
Recruiting
Intracranial ArteriosclerosisStroke
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior …
Birmingham, United StatesEst. completion Jan 31, 2027